Key Partnerships

Protagonist Therapeutics has established numerous key partnerships to support and enhance our business model. These partnerships are essential in driving innovation, advancing our research and development efforts, conducting clinical trials, and ultimately bringing our innovative therapies to market.

• Collaborations with biotech firms: Protagonist Therapeutics collaborates with other biotech companies to leverage complementary expertise, resources, and technologies. These partnerships allow us to share knowledge and work together to accelerate drug discovery and development processes.
• University research departments for R&D: We have partnerships with various university research departments to access cutting-edge scientific research, academic expertise, and state-of-the-art facilities. These collaborations help us stay at the forefront of scientific advancements and drive our R&D efforts.
• Healthcare industry partnerships for clinical trials: Protagonist Therapeutics partners with healthcare industry organizations to conduct clinical trials for our novel therapies. These partnerships are crucial in ensuring the safety and efficacy of our treatments and obtaining regulatory approval for commercialization.
• Strategic alliances with pharmaceutical distributors: We have established strategic alliances with pharmaceutical distributors to help us bring our therapies to market and reach a wider patient population. These partnerships enable us to effectively distribute and commercialize our products in global markets.

Key Activities

The key activities of Protagonist Therapeutics revolve around the research, development, and commercialization of peptide-based therapies. These activities are crucial in driving the success of the company and bringing innovative treatments to patients in need. Below are some of the key activities that Protagonist Therapeutics engages in:

• Research and development of peptide-based therapies: Protagonist Therapeutics invests heavily in researching and developing novel peptides that can be used to target specific diseases and conditions. This involves a multidisciplinary approach that includes chemistry, biology, and pharmacology.
• Clinical trials for drug effectiveness and safety: Once a potential therapy has been identified, Protagonist Therapeutics conducts clinical trials to assess its effectiveness and safety in patients. These trials are crucial in obtaining regulatory approval and bringing the therapy to market.
• Patenting novel peptides and therapeutic processes: Intellectual property is a key asset for Protagonist Therapeutics, and the company actively seeks to patent its novel peptides and therapeutic processes to protect its innovations and maintain a competitive advantage in the market.
• Marketing and advocacy to healthcare professionals: Protagonist Therapeutics engages in marketing and advocacy efforts to raise awareness about its therapies and educate healthcare professionals about their potential benefits. This involves attending conferences, publishing research, and collaborating with key opinion leaders in the field.

Overall, these key activities are essential in advancing Protagonist Therapeutics' mission of developing transformative therapies that improve the lives of patients suffering from a wide range of diseases and conditions.

Key Resources

Scientific research team expertise: Protagonist Therapeutics boasts a team of experienced scientists and researchers who are at the forefront of peptide therapy development. Their deep understanding of molecular biology and drug discovery allows them to innovate and create novel therapeutic solutions for a variety of diseases.

State-of-the-art lab facilities: The company has invested in top-of-the-line laboratory equipment and facilities to support their research and development efforts. These cutting-edge resources enable them to conduct experiments, test hypotheses, and analyze data with precision and accuracy.

Intellectual property on peptide therapies: Protagonist Therapeutics holds a portfolio of patents and intellectual property rights related to their peptide therapies. This valuable asset protects their innovations from competitors and allows them to commercialize their products in the market effectively.

Network of clinical trial participants: The company has established relationships with a diverse group of clinical trial participants who are willing to test their peptide therapies in real-world settings. This network of volunteers ensures that Protagonist Therapeutics can gather valuable data on the safety and efficacy of their drugs before seeking regulatory approval.

Overall, these key resources form the foundation of Protagonist Therapeutics' business model and enable them to drive innovation, conduct research, protect their intellectual property, and gather essential data for regulatory approval.

Value Propositions

Provides orally-administered alternatives to injectable therapies: Protagonist Therapeutics offers a unique value proposition by developing orally-administered drugs as an alternative to traditional injectable therapies. This approach eliminates the need for injections, offering a more convenient and comfortable treatment option for patients.

Focus on diseases currently treated by antibodies: The company's focus on diseases currently treated by antibodies allows Protagonist Therapeutics to target conditions with high unmet medical needs. By developing innovative oral therapies for these conditions, the company aims to provide effective treatment options where traditional therapies may fall short.

Enhanced patient comfort and compliance: By offering oral medications, Protagonist Therapeutics aims to enhance patient comfort and compliance. Eliminating the need for injections can improve patient adherence to treatment regimens and overall quality of life.

Potential for lower treatment costs and broader accessibility: Protagonist Therapeutics' oral therapies have the potential to lower treatment costs compared to traditional injectable therapies, making them more accessible to a broader patient population. This value proposition aligns with the company's mission to improve healthcare outcomes and patient access to innovative therapies.

Customer Relationships

Engagement through medical conferences and seminars: Protagonist Therapeutics prioritizes engaging with healthcare professionals and key stakeholders through participation in medical conferences and seminars. This allows the company to showcase its latest therapeutic advancements and foster relationships with potential customers.

Direct outreach to healthcare professionals: In addition to participating in conferences, Protagonist Therapeutics also engages in direct outreach to healthcare professionals. This can include personalized emails, phone calls, or in-person meetings to discuss the benefits of their treatments and how they can address specific patient needs.

Customer support for treatment administration and monitoring: Protagonist Therapeutics provides comprehensive customer support to healthcare professionals and patients for treatment administration and monitoring. This includes guidance on the proper use of their therapies, as well as tools for tracking patient progress and outcomes.

Educational resources on therapeutic advancements: To further support their customer relationships, Protagonist Therapeutics offers a range of educational resources on therapeutic advancements. This can include online webinars, whitepapers, and informational videos that keep healthcare professionals informed about the latest research and clinical developments.

• Engagement through medical conferences and seminars
• Direct outreach to healthcare professionals
• Customer support for treatment administration and monitoring
• Educational resources on therapeutic advancements

Channels

Protagonist Therapeutics has established multiple channels to reach our target customers and expand our market presence:

• Online Presence: Our corporate website serves as a key channel for customers to learn about our products and services. Through the website, customers can access information about our therapeutic offerings, place orders, and contact our customer service team for support.
• Distribution: We have partnered with healthcare facilities and pharmacies to distribute our products to a wider audience. By leveraging existing networks, we are able to reach more customers and make our products more accessible.
• Direct Sales: In addition to distribution partnerships, we also engage in direct sales to hospitals and clinics. This allows us to build relationships with healthcare providers and ensure that our products are available to patients who need them.
• Collaborations: We work closely with healthcare professionals to generate referrals and promote our products. By collaborating with key opinion leaders in the industry, we are able to raise awareness about our offerings and build trust with our target customers.

Customer Segments

Protagonist Therapeutics targets patients who are in need of treatment for diseases that are currently managed through injectables. These patients may be seeking alternative options that can provide more convenience and improved outcomes.

Our business model caters to healthcare providers who are interested in offering their patients cutting-edge treatment options. By providing innovative therapies, we aim to help healthcare providers stay at the forefront of medical advancements and improve patient care.

Protagonist Therapeutics also targets hospitals and clinics that are dedicated to adopting advanced therapy options. By offering novel therapeutic agents, we can help these healthcare facilities provide state-of-the-art treatment solutions to their patients.

Our business model includes partnerships with pharmaceutical distributors that specialize in distributing novel therapeutic agents. By collaborating with these distributors, we can ensure that our innovative treatments reach a wide range of healthcare providers and patients.

• Patients requiring treatment for diseases currently managed by injectables
• Healthcare providers looking for innovative treatment options
• Hospitals and clinics focusing on advanced therapy adoption
• Pharmaceutical distributors specializing in novel therapeutic agents

Cost Structure

The cost structure of Protagonist Therapeutics is centered around the development, testing, and commercialization of novel peptide-based drugs. The following elements make up the major components of our cost structure:

• R&D expenditure for drug development: A significant portion of our budget is allocated towards research and development activities aimed at discovering and optimizing new drug candidates. This includes costs associated with conducting preclinical studies, identifying lead compounds, and optimizing drug candidates for clinical testing.
• Costs associated with conducting clinical trials: Clinical trials are a critical part of the drug development process and require substantial investment. This includes expenses related to patient recruitment, site monitoring, data collection, and regulatory compliance.
• Patenting costs for drug and process innovations: Protecting our intellectual property through patents is essential for maintaining a competitive advantage in the pharmaceutical industry. We invest in patenting our drug candidates and process innovations to prevent competitors from replicating our discoveries.
• Marketing and sales expenses: In order to bring our drugs to market, we incur costs related to marketing, sales, and distribution. This includes advertising campaigns, sales force salaries, and distribution logistics.
• Operational costs for manufacturing and distribution: Once a drug candidate receives regulatory approval, we incur operational costs associated with manufacturing the drug at scale and distributing it to patients. This includes expenses related to manufacturing facilities, supply chain management, and quality control.

Revenue Streams

Protagonist Therapeutics generates revenue through multiple streams that are vital to the success and growth of the company.

• Sales of peptide-based therapeutic drugs: Protagonist Therapeutics develops and markets peptide-based therapeutic drugs that target specific diseases and disorders. These drugs are sold to healthcare providers, hospitals, and patients, generating revenue for the company.
• Licensing agreements with pharmaceutical companies: Protagonist Therapeutics enters into licensing agreements with pharmaceutical companies to allow them to use their patented technologies and processes for drug development. These agreements provide the company with upfront payments, milestone payments, and royalties from the sales of drugs developed by these companies.
• Grants and funding for research and development: Protagonist Therapeutics secures grants and funding from government agencies, private foundations, and other sources to support its research and development efforts. This funding allows the company to explore new therapeutic targets, conduct preclinical and clinical studies, and advance its drug candidates towards commercialization.
• Royalties from patented technologies and processes: Protagonist Therapeutics holds a portfolio of patents covering its technologies and processes for drug discovery and development. The company earns royalties from third parties who use its patented inventions, contributing to its overall revenue stream.